Table 3.
Pattern of antipsychotic prescriptions and dosing schedule of interviewed participants.
| Variable | Frequency (n) |
Percentage (%) |
|---|---|---|
| Antipsychotic therapy class | ||
| Monotherapy | 74 | 29.6 |
| Polypharmacy | 176 | 70.4 |
| Polypharmacy (oral-only combinations) | 31 | 12.0 |
| Pattern of antipsychotic prescription | ||
| Oral FGAs monotherapy | 37 | 15.2 |
| Oral SGAs monotherapy | 34 | 13.6 |
| i.m. FGAs monotherapy | 3 | 1.2 |
| Combination of oral FGAs | 30 | 12.0 |
| Oral FGAs + oral SGAs | 1 | 0.4 |
| i.m. FGAs + oral FGAs | 111 | 44.0 |
| i.m. FGAs + oral SGAs | 34 | 14.0 |
| Total SGAs prescriptions | 69 | 27.6 |
| Dosing schedule | ||
| Once daily | 92 | 36.8 |
| Twice daily | 13 | 5.2 |
| Monthly depot | 3 | 1.2 |
| Once daily + monthly depot | 106 | 42.4 |
| Twice daily + monthly depot | 34 | 13.6 |
| Thrice daily + monthly depot | 2 | 0.8 |
FGA, first-generation antipsychotic; i.m., intramuscular depot injection; SGA, second-generation antipsychotic.